Abstract P172 – Table 1. Baseline characteristics (n = 34).
	Arm A n = 17	Arm B n = 17	p
	DTG/3TC/ABC	B/F/TAF
Age, years (median, IQR)	50.4 (41.8 to 56.8)	51.8 (30.0 to 58.1)	0.718
Male gender, n (%)	12 (70.6)	13 (76.5)	1.000
Caucasian ethnicity, n (%)	15 (88.2)	12 (70.6)	0.398
Risk category			0.308
Heterosexuals, n (%)	8 (47.1)	4 (23.5)
Men who have sex with men, n (%)	6 (35.3)	9 (52.9)
Injecting drug users, n (%)	1 (5.9)	0
Other/unknown, n (%)	2 (11.8)	4 (23.5)
Years from HIV diagnosis (median, IQR)	10.7 (4.9 to 21.5)	9.9 (5.4 to 19.0)	0.796
Years from first ART (median, IQR)	9.8 (4.7 to 21.5)	9.8 (4.7 to 14.8)	0.570
Nadir CD4, cells/mm3 (median, IQR)	299 (123 to 420)	334 (138 to 516)	0.796
Years on DTG/3TC/ABC (median, IQR)	4.6 (3.2 to 4.9)	4.6 (3.6 to 5.2)	0.399
Years from last HIV‐RNA >50 copies/mL (median, IQR)	6.2 (3.7 to 8.2)	6.0 (4.2 to 11.7)	0.419
HCV Ab+, n (%)	0	0
BMI, kg/m2 (median, IQR)	23.5 (21.6 to 28.7)	24.5 (19.9 to 29.4)	0.896
CD4, cells/mm3 (median, IQR)	613 (457 to 995)	784 (522 to 1288)	0.296
CD4/CD8 ratio (median, IQR)	0.99 (0.77 to 1.39)	0.84 (0.42 to 1.65)	0.692